![Milestone Pharmaceuticals Inc](/common/images/company/N_MIST.png)
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1015 | 4.57516339869 | 2.2185 | 2.38 | 2.115 | 899436 | 2.23802954 | CS |
4 | 0.33 | 16.5829145729 | 1.99 | 2.38 | 1.87 | 832452 | 2.08799897 | CS |
12 | 0.47 | 25.4054054054 | 1.85 | 2.75 | 1.68 | 625250 | 2.06745815 | CS |
26 | 0.89 | 62.2377622378 | 1.43 | 2.75 | 1.29 | 408472 | 1.92601656 | CS |
52 | 0.77 | 49.6774193548 | 1.55 | 2.75 | 1.12 | 320305 | 1.83356006 | CS |
156 | -3.92 | -62.8205128205 | 6.24 | 9.8465 | 1.12 | 254461 | 3.60774326 | CS |
260 | -17.84 | -88.4920634921 | 20.16 | 21.43 | 1.12 | 537211 | 5.98158276 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales